Venture Capital
New York, New York, 10011
Catalio was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein to invest in the next generation of category-defining life sciences companies around the globe. Our mission is to produce extraordinary returns by creating and sustaining life sciences companies that combine the best science and technology with the best management and execution. To achieve this objective, we work with an elite group of the world’s best scientists, engineers and clinicians – the Catalio Venture Partners – to identify breakthrough biotechnologies; co-invest with top-tier funds; and recruit A-list talent from our collective networks.
05324sbs
